US 2024/0197666 A1Published application

Diterpenoid compounds that act on protein kinase c (pkc)

AssigneeK-Gen Therapeutics, Inc.

InventorsChun Jiang, Ruihong CHEN

Life of this patent

Estimating the term…

Abstract

This present disclosure relates to a method of stimulating an immune response using compounds that activate protein kinase C (PKC), including for treatment of a cancer, a precancerous lesion, a benign tumor, or a wound.

Claims133

Dependent claims

A method of stimulating an immune response, comprising administering to a subject in need thereof an effective amount of a PKC activating compound.

Dependencies are inferred from the claim text.

Facts

Application: 18/283,787Filed 23 Mar 2022
Priority: 23 Mar 2021
Published: 20 Jun 2024
Term ends: Not estimatedThe source records don’t support an estimate.

Classification34 codes

A61K 31/22
Of carboxylic acids: of acyclic acids, e.g. pravastatin
C07C 69/013
Esters of carboxylic acids; Esters of carbonic or haloformic acids: esters of alcohols having the esterified hydroxy group bound to a carbon atom…
A61K 31/122
Ketones: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 31/222
Of acyclic acids, e.g. pravastatin: with compounds having aromatic groups, e.g. dipivefrine, ibopamine

Family

Application63/164,704Us provisional application · filed 23 Mar 2021
US 2024/0197666 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results